These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 14606518)
1. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK. Koike M; Yamanaka Y; Inoue M; Tanaka H; Nishimura R; Seino Y J Bone Miner Res; 2003 Nov; 18(11):2043-51. PubMed ID: 14606518 [TBL] [Abstract][Full Text] [Related]
2. PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation. Yamanaka Y; Tanaka H; Koike M; Nishimura R; Seino Y J Bone Miner Res; 2003 Aug; 18(8):1395-403. PubMed ID: 12929929 [TBL] [Abstract][Full Text] [Related]
3. Molecular basis for the treatment of achondroplasia. Yamanaka Y; Ueda K; Seino Y; Tanaka H Horm Res; 2003; 60 Suppl 3():60-4. PubMed ID: 14671399 [TBL] [Abstract][Full Text] [Related]
4. Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCgamma-activated STAT1. Harada D; Yamanaka Y; Ueda K; Nishimura R; Morishima T; Seino Y; Tanaka H Bone; 2007 Aug; 41(2):273-81. PubMed ID: 17561467 [TBL] [Abstract][Full Text] [Related]
5. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587 [TBL] [Abstract][Full Text] [Related]
6. PTH has the potential to rescue disturbed bone growth in achondroplasia. Ueda K; Yamanaka Y; Harada D; Yamagami E; Tanaka H; Seino Y Bone; 2007 Jul; 41(1):13-8. PubMed ID: 17466614 [TBL] [Abstract][Full Text] [Related]
7. Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations. Ronchetti D; Greco A; Compasso S; Colombo G; Dell'Era P; Otsuki T; Lombardi L; Neri A Oncogene; 2001 Jun; 20(27):3553-62. PubMed ID: 11429702 [TBL] [Abstract][Full Text] [Related]
8. Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells. Henderson JE; Naski MC; Aarts MM; Wang D; Cheng L; Goltzman D; Ornitz DM J Bone Miner Res; 2000 Jan; 15(1):155-65. PubMed ID: 10646125 [TBL] [Abstract][Full Text] [Related]
9. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Naski MC; Wang Q; Xu J; Ornitz DM Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234 [TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Murakami S; Balmes G; McKinney S; Zhang Z; Givol D; de Crombrugghe B Genes Dev; 2004 Feb; 18(3):290-305. PubMed ID: 14871928 [TBL] [Abstract][Full Text] [Related]
12. Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization. Adar R; Monsonego-Ornan E; David P; Yayon A J Bone Miner Res; 2002 May; 17(5):860-8. PubMed ID: 12009017 [TBL] [Abstract][Full Text] [Related]
13. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2. Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Yasoda A; Komatsu Y; Chusho H; Miyazawa T; Ozasa A; Miura M; Kurihara T; Rogi T; Tanaka S; Suda M; Tamura N; Ogawa Y; Nakao K Nat Med; 2004 Jan; 10(1):80-6. PubMed ID: 14702637 [TBL] [Abstract][Full Text] [Related]
15. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Su WC; Kitagawa M; Xue N; Xie B; Garofalo S; Cho J; Deng C; Horton WA; Fu XY Nature; 1997 Mar; 386(6622):288-92. PubMed ID: 9069288 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. Remacle-Bonnet MM; Garrouste FL; Heller S; André F; Marvaldi JL; Pommier GJ Cancer Res; 2000 Apr; 60(7):2007-17. PubMed ID: 10766192 [TBL] [Abstract][Full Text] [Related]
17. Expression of fibroblast growth factor receptor 3 by fibroblast growth factor 2 in cultured chick embryo chondrocytes. Suh JY; Kim YS; Park JW; Sonn JK; Kim WT Cell Biol Int; 2005 Mar; 29(3):203-12. PubMed ID: 15878293 [TBL] [Abstract][Full Text] [Related]
18. Co-ordination of TGF-beta and FGF signaling pathways in bone organ cultures. Mukherjee A; Dong SS; Clemens T; Alvarez J; Serra R Mech Dev; 2005 Apr; 122(4):557-71. PubMed ID: 15804568 [TBL] [Abstract][Full Text] [Related]
19. Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. L'Hôte CG; Knowles MA Exp Cell Res; 2005 Apr; 304(2):417-31. PubMed ID: 15748888 [TBL] [Abstract][Full Text] [Related]
20. Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells. Grey A; Chen Q; Xu X; Callon K; Cornish J Endocrinology; 2003 Nov; 144(11):4886-93. PubMed ID: 12960100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]